Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2017 Update of the Drug Resistance Mutations in HIV-1.

Literature DB >> 28208121

2017 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M Wensing¹, Vincent Calvez², Huldrych F Günthard³, Victoria A Johnson⁴, Roger Paredes⁵, Deenan Pillay⁶, Robert W Shafer⁷, Douglas D Richman⁸.

Abstract

The 2017 edition of the IAS-USA drug resistance mutations list updates the figures last published in November 2015. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The figures are designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs and, therefore, in making clinical decisions regarding antiretroviral therapy.

Entities: Species

Mesh：

Year: 2016 PMID： 28208121 PMCID： PMC5677049

Source DB: PubMed Journal: Top Antivir Med ISSN： 2161-5853

3 in total

1. 2015 Update of the Drug Resistance Mutations in HIV-1.

Authors: Annemarie M Wensing; Vincent Calvez; Huldrych F Günthard; Victoria A Johnson; Roger Paredes; Deenan Pillay; Robert W Shafer; Douglas D Richman
Journal: Top Antivir Med Date: 2015 Oct-Nov

2. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Authors: Huldrych F Günthard; Michael S Saag; Constance A Benson; Carlos del Rio; Joseph J Eron; Joel E Gallant; Jennifer F Hoy; Michael J Mugavero; Paul E Sax; Melanie A Thompson; Rajesh T Gandhi; Raphael J Landovitz; Davey M Smith; Donna M Jacobsen; Paul A Volberding
Journal: JAMA Date: 2016-07-12 Impact factor: 56.272

3. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Authors: Martin S Hirsch; Huldrych F Günthard; Jonathan M Schapiro; Françoise Brun-Vézinet; Bonaventura Clotet; Scott M Hammer; Victoria A Johnson; Daniel R Kuritzkes; John W Mellors; Deenan Pillay; Patrick G Yeni; Donna M Jacobsen; Douglas D Richman
Journal: Clin Infect Dis Date: 2008-07-15 Impact factor: 9.079

3 in total

106 in total

1. Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.

Authors: Perrine Soret; Marta Avalos; Linda Wittkop; Daniel Commenges; Rodolphe Thiébaut
Journal: BMC Med Res Methodol Date: 2018-12-04 Impact factor: 4.615

2. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

Authors: Thabo Diphoko; Simani Gaseitsiwe; Ishmael Kasvosve; Sikhulile Moyo; Harriet Okatch; Rosemary Musonda; Mark Wainberg; Joseph Makhema; Richard Marlink; Vladimir Novitsky; Max Essex
Journal: AIDS Res Hum Retroviruses Date: 2018-06-12 Impact factor: 2.205

3. Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy.

Authors: Vinie Kouamou; Justen Manasa; David Katzenstein; Alan M McGregor; Chiratidzo E Ndhlovu; Azure T Makadzange
Journal: AIDS Date: 2019-09-01 Impact factor: 4.177

Review 4. Decoding HIV resistance: from genotype to therapy.

Authors: Irene T Weber; Robert W Harrison
Journal: Future Med Chem Date: 2017-08-09 Impact factor: 3.808

5. Impact of HIV-1 Integrase L74F and V75I Mutations in a Clinical Isolate on Resistance to Second-Generation Integrase Strand Transfer Inhibitors.

Authors: Atsuko Hachiya; Karen A Kirby; Yoko Ido; Urara Shigemi; Masakazu Matsuda; Reiko Okazaki; Junji Imamura; Stefan G Sarafianos; Yoshiyuki Yokomaku; Yasumasa Iwatani
Journal: Antimicrob Agents Chemother Date: 2017-07-25 Impact factor: 5.191

Review 6. Molecular evolution methods to study HIV-1 epidemics.

Authors: Juan Á Patiño-Galindo; Fernando González-Candelas
Journal: Future Virol Date: 2018-05-21 Impact factor: 1.831

7. High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children.

Authors: M H W Huibers; P Moons; M Cornelissen; F Zorgdrager; N Maseko; M B Gushu; O H Iwajomo; M Boele van Hensbroek; J C J Calis
Journal: J Antimicrob Chemother Date: 2018-12-01 Impact factor: 5.790

Review 8. The dawn of precision medicine in HIV: state of the art of pharmacotherapy.

Authors: Ying Mu; Sunitha Kodidela; Yujie Wang; Santosh Kumar; Theodore J Cory
Journal: Expert Opin Pharmacother Date: 2018-09-20 Impact factor: 3.889

9. New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations.

Authors: Thibaut Davy-Mendez; Joseph J Eron; Laurence Brunet; Oksana Zakharova; Ann M Dennis; Sonia Napravnik
Journal: AIDS Date: 2018-11-13 Impact factor: 4.177

10. Eight-day Inpatient Directly Observed Therapy for Antiretroviral Therapy (ART) Failure: A Tool For Preventing Unnecessary ART Changes and Optimizing Adherence Support.

Authors: Nicole E Winchester; Frank Maldarelli; Yolanda Mejia; Nicola Dee; Robin Dewar; Elizabeth Laidlaw; Safia S Kuriakose; Pamela Stoll; Michael Proschan; H Clifford Lane; Alice K Pau
Journal: Clin Infect Dis Date: 2020-03-03 Impact factor: 9.079